MedPath

ong term follow up in patients with intermittent claudication randomized for supervised exercise training or endovascular revascularizatio

Recruiting
Conditions
Intermittent claudication
limping
10024450
10047079
Registration Number
NL-OMON33307
Lead Sponsor
Ikazia Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
151
Inclusion Criteria

As this study is a continuation of the CETAC study the inclusion criteria have
been described extensively in the CETAC study.

Exclusion Criteria

As this study is a continuation of the CETAC study the exclusion criteria have
been described extensively in the CETAC study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>maximum walking distance</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>preference based utilities (EQ-5Dand Rating Scale), health status QoL scores<br /><br>(SF-36 and VascuQol), ankle-brachial index, maximum painless walking distance,<br /><br>clinical success, risk factor score, number of events, patency rates</p><br>
© Copyright 2025. All Rights Reserved by MedPath